sorafenib has been researched along with corosolic acid in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (corosolic acid) | Trials (corosolic acid) | Recent Studies (post-2010) (corosolic acid) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 155 | 3 | 105 |
| Protein | Taxonomy | sorafenib (IC50) | corosolic acid (IC50) |
|---|---|---|---|
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 6.245 | |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | Homo sapiens (human) | 0.81 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ku, CY; Lin, HY; Lin, JY; Lu, SC; Wang, YR | 1 |
1 other study(ies) available for sorafenib and corosolic acid
| Article | Year |
|---|---|
Corosolic Acid Inhibits Hepatocellular Carcinoma Cell Migration by Targeting the VEGFR2/Src/FAK Pathway.
Topics: Actins; Adenosine Triphosphate; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Down-Regulation; Drug Synergism; Focal Adhesion Kinase 1; Hep G2 Cells; Humans; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Signal Transduction; Sorafenib; src-Family Kinases; Triterpenes; Vascular Endothelial Growth Factor Receptor-2 | 2015 |